Varex Imaging Corporation (VREX)

From the record

Varex Imaging Corporation's filings since 2017 show 5 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2019-12-23); an auditor change (8-K item 4.01, the latest 2021-04-01); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2020-08-13) (its current reports).

From the record

Varex Imaging Corporation's 5 filed years say what it did: revenue went from $818 million in fiscal 2021 to $845 million in fiscal 2025, up 0.8% a year; it rose in 3 of 4 years; the deepest fall was 9% from fiscal 2023 to fiscal 2024; net income was positive in 3 of 5 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-10-03, Varex Imaging Corporation's diluted share count shrank about 0.2% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 3 sales and 0 purchases of their own stock on the open market in the year to 2026-10-14 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-10-03, Varex Imaging Corporation lost about 14 cents for every dollar of shareholders' money, and gross profitability: its products earned about 26 cents per dollar of everything the company owns. Leverage: it owed about 56 cents per dollar of assets, and net share issuance: its share count grew 1.5% over the year (the filed statements).

From the record

Varex Imaging Corporation's standing among 12 graded names in its industry family: revenue of $845 million in fiscal 2025 ranks in the top 23% by size; a net margin of -8.3% ranks in the bottom 21%; revenue growth of -0.6% a year over the last 3 filed years ranks in the bottom 41% (its annual reports).

From the record

Varex Imaging Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Sanyal, Sunny (President and CEO, as filed), filing under that title since 2017-01-19, 9.8 years (top 28% of its family); the 14 officers and directors filing in the last fifteen months have been on the record a median of 6.2 years (top 28%); 2 officer or director changes were reported on Form 8-K since 2023-11-13, against the 14 people in charge now (top 25%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Varex Imaging Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $145 million against debt of $366 million leaves -20% of its assets as net cash, bottom 21% of its family; cash from operations less capital spending is 2.2% of revenue (bottom 46%); a gross margin of 34.4% (bottom 35%); research spending of 10.8% of revenue (bottom 45%) (its annual report).

From the record

Varex Imaging Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew -0.6% a year over the last three filed years against 0.8% over all 5, slowing (top 50% of its family); the newest year grew 4.1% (bottom 46%); research spending grew 5.7% a year (bottom 41%); capital spending grew 2.4% a year (top 50%) (its annual reports). Varex Imaging Corporation reported 2 lines of business in fiscal 2025: Medical at $593 million (70%), Industrial at $252 million (30%); 2 of 2 grew against the year before (its annual report).

From the record

Varex Imaging Corporation's newest year against its own record: revenue of $845 million in fiscal 2025 came in 7.2% above the $788 million its prior three years' pace pointed to (top 41% of its family); net income of $70 million against a prior three-year average of $10 million (bottom 4%); a net margin of -8.3% against 0.9% before (bottom 13%) (its annual reports).